Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-29Clinical Trial Results: Tofacitinib in Recurrent GBM Patients [Phase 3]
Phase 3 trial results for tofacitinib in recurrent glioblastoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Update: Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma [Phase 3]
Phase 3 trial update evaluating adding lomustine to standard temozolomide and radiation for newly diagnosed MGMT-methylated glioblastoma; st…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Investigational Imaging Technique During Brain Surgery [NA]
A clinical trial evaluating an investigational imaging technique during brain tumor surgery has been suspended. The study involves astrocyto…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: POSitron Emission Imaging Using 18F-FDOPA in Neurooncology [NA]
This clinical trial update reports on a study evaluating PET imaging with 18F-FDOPA for glioblastoma in neuro-oncology. The trial status is …
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM [Phase 1]
Phase 1 clinical trial update for recurrent glioblastoma evaluating a TIM-3–targeting antibody in combination with PD-1 blockade and stereot…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Efficacy of Zoster Vaccination in Glioblastoma Patients [Phase 4]
Phase 4 clinical trial evaluating the efficacy of zoster vaccination in patients with glioblastoma. The study is currently not yet recruitin…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature [Phase 2]
Phase 2 proof-of-concept study of ACT001 in adults with recurrent glioblastoma has been suspended.
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma [Phase 1]
Phase 1 study of RMC-5552 as monotherapy in adults with recurrent glioblastoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma [Phase 2]
A Phase 2 clinical trial update exploring whether peripheral blood immunologic biomarkers predict response to adjuvant immune checkpoint inh…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
This clinical trial update summarizes the safety and feasibility findings of using ExAblate focused ultrasound to disrupt the blood-brain ba…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma [Phase 1]
This Phase 1 trial tested adding a ketogenic diet to standard radiotherapy and temozolomide in glioblastoma and has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: APT-weighted and Diffusion MRI for Characterizing Tumor Infiltration in High-Grade Gliomas
This clinical trial update describes a study using APT-weighted and diffusion MRI to characterize tumor infiltration in high-grade gliomas. …
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme [Phase 2]
This is an update on a Phase 2 clinical trial evaluating Berubicin in adults with glioblastoma, currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/Phase 2 study evaluating the combination of durvalumab with hypofractionated …
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study [NA]
Completed proof-of-concept clinical trial evaluating the ability of MRI spectroscopy to delineate tumor areas enriched for glioblastoma stem…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas [Phase 1]
Phase 1 clinical trial update exploring vorinostat with temozolomide for malignant gliomas in adults, with active-not-recruiting status acro…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients [NA]
Completed clinical trial evaluating the NaviFUS system as an add-on to Bevacizumab for recurrent glioblastoma, reporting efficacy and safety…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma [EARLY_Phase 1]
An early-phase clinical trial is evaluating the safety and immunogenicity of cancer vaccines aimed at preventing glioblastoma recurrence. Th…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma [NA]
This document reports the completion of a clinical trial evaluating metabolic therapy in conjunction with standard treatment for Glioblastom…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: A Phase I Study to Evaluate the Safety and Tolerability of JL15003 Injection in Patients With Recurrent Glioblastoma [Phase 1]
Phase I study evaluating safety and tolerability of JL15003 injection in patients with recurrent glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Pediatric Long-Term Follow-up and Rollover Study [Phase 4]
Pediatric long-term follow-up and rollover study (Phase 4) sponsored by Novartis is active but not recruiting, tracking outcomes in children…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Phase 1 Open-label Study of 123I-ATT001 in Subjects With Relapsed Glioblastoma [Phase 1]
A Phase 1 open-label study evaluating the radiopharmaceutical 123I-ATT001 in relapsed glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM [NA]
This update reports the completion of a pivotal randomized study evaluating Optune Tumor Treating Fields in combination with radiotherapy an…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy
A completed clinical study evaluating signatures of Tumor Treating Fields therapy (NovoTTF-100A System) in glioblastoma patients, with autop…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma [Phase 1]
Phase 1 trial evaluating ABBV-637 or ABBV-155 in combination with ERAS-801 for glioblastoma and gliosarcoma is currently recruiting.